GEODE CAPITAL MANAGEMENT, LLC

Position in ESLA — Estrella Immunopharma, Inc.

CIK 1214717 BOSTON, MA

Position in ESLA

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$146,973

-$19,960 QoQ

Shares Held

141,321

-10.3% QoQ

Ownership

0.325%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 15 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,296,497 across 521 Biotechnology names. ESLA ranks #419 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$146,973	141,321	-10.3%	Shares	Defined	2026-08-12
2026-03-31	$166,933	157,485	+43.4%	Shares	Defined	2026-05-15
2025-12-31	$171,299	109,808	+8.2%	Shares	Defined	2026-02-09
2025-09-30	$116,713	101,490	-1.8%	Shares	Defined	2025-11-12
2025-06-30	$99,203	103,337	+3.2%	Shares	Defined	2025-08-08
2025-03-31	$92,859	100,173	+7.2%	Shares	Defined	2025-05-13
2024-12-31	$112,101	93,418	+22.0%	Shares	Defined	2025-02-12
2024-09-30	$88,804	76,556	+31.5%	Shares	Defined	2024-11-12
2024-06-30	$61,124	58,214	0.0%	Shares	Defined	2024-08-09
2024-03-31	$72,185	58,214	+3.6%	Shares	Defined	2024-05-13
2023-12-31	$62,398	56,215	—	Shares	Defined	2024-02-13
No filing history on record for this holder in this stock.